Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
06/02/1999 | EP0919541A1 Naphthalene compounds, process for their preparation and their pharmaceutical compositions |
06/02/1999 | EP0918747A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF |
06/02/1999 | EP0918746A1 Immunotherapeutic agents and their use in the reduction of cytokine levels |
06/02/1999 | EP0918514A1 Triaryl methane compounds for sickle cell disease |
06/02/1999 | EP0625138B1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect |
06/02/1999 | CN1218450A Preparation of gamma-butyrolactone, butane-1,4-diol and tetrahydrofuran |
06/02/1999 | CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
06/01/1999 | US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism |
06/01/1999 | US5908849 Anti-oxidant esters of non-steroidal anti-inflammatory agents |
05/27/1999 | WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
05/27/1999 | WO1999025686A1 Cyclic amine derivatives and their use as drugs |
05/27/1999 | WO1999025684A1 Method of synthesis of pyrrole amides |
05/27/1999 | WO1999025678A1 Process for preparing gamma-butyrolactone, butane-1,4-diol and tetrahydrofuran |
05/27/1999 | WO1999025675A1 Process for the preparation of butane-1,4-diol, gamma-butyrolactone and tetrahydrofuran |
05/27/1999 | WO1999025358A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
05/27/1999 | CA2310630A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
05/27/1999 | CA2310095A1 Method of synthesis of pyrrole amides |
05/27/1999 | CA2309997A1 Process for preparing gamma-butyrolactone, butane-1,4-diol and tetrahydrofuran |
05/27/1999 | CA2309992A1 Process for the preparation of butane-1,4-diol, gamma-butyrolactone and tetrahydrofuran |
05/26/1999 | EP0918296A1 Method of virtual retrieval of analogs of lead compounds by constituting potential libraries |
05/26/1999 | EP0917909A1 Preparation process of a coated catalyst for the synthesis of maleic anhydride in the gas phase |
05/26/1999 | EP0917871A2 Cosmetic and pharmaceutical compositions comprising ascorbic acid derivatives |
05/26/1999 | EP0917464A1 Use of amines to produce drugs for preventing tumour cell proliferation |
05/26/1999 | EP0917462A1 Cell adhesion inhibitors |
05/26/1999 | EP0873294A4 Production of levulinic acid from carbohydrate-containing materials |
05/26/1999 | EP0686625B1 Anthranilic acid derivative |
05/26/1999 | CN1217720A Benzofuryl derivatives and their use |
05/26/1999 | CN1217719A Novel benzofuranone derivative and process for producing same |
05/25/1999 | US5906993 Anticancer, antitumor agent |
05/25/1999 | US5906989 Cyclopentane(ENE) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
05/20/1999 | WO1999024480A1 Method for coupling living cationic polymers |
05/20/1999 | WO1999024460A2 Dipeptide nitriles |
05/20/1999 | WO1999024446A1 Metallocenes and catalysts for olefin-polymerisation |
05/20/1999 | WO1999024442A1 Novel signal transduction inhibitors, compositions containing them |
05/20/1999 | WO1999024385A1 Fluorinated derivatives of phenanthrene and the utilization thereof in liquid crystal mixtures |
05/20/1999 | DE19751200A1 New epothilone derivatives |
05/20/1999 | CA2309792A1 Novel signal transduction inhibitors, compositions containing them |
05/20/1999 | CA2277127A1 Metallocenes and catalysts for olefin-polymerisation |
05/19/1999 | EP0916663A1 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3,13(16), 14-clerodatrien-2-one (Esculentin A) and 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3, 12, 14-clerodatrien-2Beta-isovaleryloxy-6Beta, 7Alpha-diol (Esculentin B), a process for their preparation, and their use in the manufacture of medicaments |
05/19/1999 | EP0916662A2 Ascorbylsorbate |
05/19/1999 | EP0916651A1 Phenylalkylcarboxylic acid derivatives |
05/19/1999 | EP0916397A2 Apparatus and method used in multiple, simultaneous synthesis of general compounds |
05/19/1999 | EP0915868A1 Carbanilides used as pesticides |
05/19/1999 | EP0915866A1 Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid |
05/19/1999 | EP0915863A1 Dihydrofuran carboxamides |
05/19/1999 | EP0915862A1 Manufacture of fatty acid esters of sorbitan as surfactants |
05/19/1999 | EP0915855A1 Novel compounds with analgesic effect |
05/19/1999 | EP0915846A2 2- and 2,5-substituted phenylketoenols |
05/19/1999 | EP0915837A1 Glyoxylic acid derivatives |
05/19/1999 | CN1216987A Process for preparing phthalides |
05/19/1999 | CN1216978A New vitamin-D derivatives with carbo- or heterocyclic substitutents at C-25, process for the prodn. intermediate products and their use for producing medicaments |
05/19/1999 | CN1043425C Sub-salicylic amino transition metal compounding agent and it mfg. method |
05/18/1999 | US5905159 Method of producing 1,4-butanediol and tetrahydrofuran from furan |
05/18/1999 | US5905090 Immunosuppressants and/or antiinflammatories |
05/18/1999 | US5905088 Skin disorders, rheumatic diseases, respiratory system or cardiovascular disorders and opthalmological disorders |
05/18/1999 | US5904923 Methods for preparing pharmaceutical compositions and using same to treat drug addiction |
05/18/1999 | CA2161284C Novel o-arylmethyl n-thioacyl hydroxylamines, processes for their preparation and pharmaceutical compositions containing them |
05/18/1999 | CA2111820C Method for reducing an .alpha.,.beta.-unsaturated ketone |
05/18/1999 | CA2109744C 1-phenylbicyclo¬2.2.2|octane derivatives, a process for their preparation and pharmaceutical compositions holding same |
05/18/1999 | CA1340543C Pharmaceutically active compounds |
05/14/1999 | WO1999023587A2 Method of virtual retrieval of analogs of lead compounds |
05/14/1999 | WO1999023087A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors |
05/14/1999 | WO1999023086A1 Process for the preparation of hydroxy substituted gamma butyrolactones |
05/14/1999 | WO1999022757A1 Hypusine reagent for peptide synthesis |
05/14/1999 | WO1999022720A2 Selective cyclooxygenase-2 inhibitors against premature labor |
05/14/1999 | WO1999007692A3 New epothilone derivatives, method for producing same and their pharmaceutical use |
05/14/1999 | WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life |
05/14/1999 | WO1999001423A8 Glucagon antagonists/inverse agonists |
05/14/1999 | WO1998051289A3 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
05/14/1999 | CA2308639A1 Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor |
05/14/1999 | CA2308305A1 Hypusine reagent for peptide synthesis |
05/14/1999 | CA2307853A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors |
05/14/1999 | CA2306822A1 Method of virtual retrieval of analogs of lead compounds |
05/14/1999 | CA2253164A1 Apparatus and method used in multiple, simultaneous synthesis of general compounds |
05/12/1999 | EP0915091A2 Process of preparation of five- or sixmembered cyclic ethers, in particular anhydropolyols |
05/12/1999 | EP0915087A2 Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them |
05/12/1999 | EP0915073A1 Process for producing optically active isomers of tricyclic compounds |
05/12/1999 | EP0914605A1 Molecular model for vla-4 inhibitors |
05/12/1999 | EP0914334A1 Process and intermediates for the synthesis of lhrh antagonists |
05/12/1999 | EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
05/12/1999 | EP0844994B1 Butyrolactone-preparation process |
05/12/1999 | EP0751940B1 Sesquiterpenic derivatives |
05/12/1999 | CN1216522A Therapeutic agent for diabetes |
05/12/1999 | CN1043349C New sulfuric acid esters of sugar alcohols and producing process and its application |
05/12/1999 | CN1043346C Preparation of tetronsaureallylestern |
05/11/1999 | US5902885 Production of L-ascorbic acid |
05/11/1999 | US5902824 Phenyldihydrobenzofuranes |
05/11/1999 | US5902809 Arglabin compounds and therapeutic uses thereof |
05/11/1999 | CA2192815C Novel 2,3-dihydrobenzofuran derivative, method for producing the same, and use thereof |
05/11/1999 | CA2079485C Chelator compositions comprising oxime compounds |
05/06/1999 | WO1999021847A1 Novel fragrance compound |
05/06/1999 | WO1999021830A1 Process for stereoselective synthesis of prostacyclin derivatives |
05/06/1999 | WO1999021828A1 Synthesis and isolation of n-(aryl or heteroaryl)-alkyl-n-hydroxyurea |
05/06/1999 | WO1999021824A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
05/06/1999 | WO1999021823A1 Optically active intermediates for the preparation of optically active substituted oximes, hydrazones and olefins useful as neurokinin antagonists |
05/06/1999 | WO1999021817A1 Reaction of alkenes with epoxides, the products thereof and their use as fragrance compounds |
05/06/1999 | EP0913430A1 Condensed azo compound and process for producing the same |
05/06/1999 | EP0912540A1 Process for preparing phthalides |
05/06/1999 | EP0912539A1 Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption |
05/06/1999 | EP0912538A1 Process for preparing 2,3-dihydro-2-methyl-2-alkylbenzofuran derivatives |